Conjugation with loxoribine and mannan improves the immunogenicity of Mycobacterium tuberculosis CFP10-TB10.4 fusion protein
- 18 February 2022
- journal article
- research article
- Published by Elsevier in European Journal of Pharmaceutics and Biopharmaceutics
- Vol. 172, 193-202
Abstract
No abstract availableKeywords
Funding Information
- National Key Research and Development Program of China (2018YFA0900804)
- National Natural Science Foundation of China (31970875)
- Natural Science Foundation of Beijing Municipality (M21013)
This publication has 45 references indexed in Scilit:
- Modern Subunit Vaccines: Development, Components, and Research OpportunitiesChemMedChem, 2013
- Mannan-binding lectin directly interacts with Toll-like receptor 4 and suppresses lipopolysaccharide-induced inflammatory cytokine secretion from THP-1 cellsCellular & Molecular Immunology, 2011
- Conjugation of ovalbumin to trimethyl chitosan improves immunogenicity of the antigenJournal of Controlled Release, 2010
- Toll-Like Receptor Agonists in Cancer TherapyImmunotherapy, 2009
- Influence of the mannose receptor in host immune responsesImmunobiology, 2009
- Immune sensing of Candida albicans requires cooperative recognition of mannans and glucans by lectin and Toll-like receptorsJournal of Clinical Investigation, 2006
- Mannan-MUC1–Pulsed Dendritic Cell Immunotherapy: A Phase I Trial in Patients with AdenocarcinomaClinical Cancer Research, 2006
- The Toll‐like receptor 7 (TLR7)‐specific stimulus loxoribine uncovers a strong relationship within the TLR7, 8 and 9 subfamilyEuropean Journal of Immunology, 2003
- Comparative Evaluation of Low-Molecular-Mass Proteins fromMycobacterium tuberculosisIdentifies Members of the ESAT-6 Family as Immunodominant T-Cell AntigensInfection and Immunity, 2000
- Quantitation of ϵ-amino group using amino acids as reference standards by trinitrobenzene sulfonic acidJournal of Immunological Methods, 1994